Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer
Menée in vitro puis in vivo à l'aide de xénogreffes et d'un modèle de métastases ganglionnaires, cette étude évalue l'effet antitumoral d'une photothérapie dynamique utilisant un adénovirus oncolytique comportant le promoteur du gène de la protéine humaine TERT et le gène codant pour une protéine fluorescente rouge générant, après excitation lumineuse, des espèces réactives de l'oxygène
Photodynamic therapy (PDT) is a minimally invasive antitumor therapy that eradicates tumor cells through a photosensitizer-mediated cytotoxic effect upon light irradiation. However, systemic administration of photosensitizer often makes it difficult to avoid a photosensitive adverse effect. A red fluorescent protein KillerRed generates reactive oxygen species (ROS) upon green light irradiation. Here we show the therapeutic potential of a novel tumor-specific replicating photodynamic viral agent (TelomeKiller) constructed by using the human telomerase reverse transcriptase (hTERT) promoter. We investigated the light-induced antitumor effect of TelomeKiller in several types of human cancer cell lines. Relative cell viability was investigated using an XTT assay. The in vivo antitumor effect was assessed using subcutaneous xenografted tumor and lymph node metastasis models. KillerRed accumulation resulted in ROS generation and apoptosis in light-irradiated cancer cells. Intratumoral injection of TelomeKiller efficiently delivered the KillerRed protein throughout the tumors and exhibited a long-lasting antitumor effect with repeated administration and light irradiation in mice. Moreover, intratumorally injected TelomeKiller could spread into the regional lymph node area and eliminate micrometastasis with limited-field laser irradiation. Our results suggest that KillerRed has great potential as a novel photosensitizer if delivered with a tumor-specific virus-mediated delivery system. TelomeKiller-based PDT is a promising antitumor strategy to efficiently eradicate tumor cells.
http://mct.aacrjournals.org/content/early/2015/12/01/1535-7163.MCT-15-0344.abstract